Dr. Eric Topol posits that digital services allow physicians the “gift of time” to interact on a more personal level with patients and so should be adopted. AI imaging tools fall in that same category and can deliver even better personalized care.
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
GLP-1 medicines, initially developed for blood glucose and weight control, improve outcomes in people with cardiovascular, kidney, liver, arthritis, and sleep apnea disorders, actions mediated…
This cohort study evaluates the association of glucagon-like peptide 1 receptor agonists (GLP-1RAs) semaglutide and tirzepatide with incidence of neurodegenerative and cerebrovascular diseases in patients…
Exercise enhances antitumor immunity and immunotherapy effectiveness by increasing microbiota-derived formate, which boosts CD8 T cell function and may serve as a biomarker of melanoma…
The Global Neurodegeneration Proteomics Consortium is a multi-national database that aims to leverage proteomics and clinical data to understand and improve …
Nature Medicine – Proteomic analysis of paired cerebrospinal fluid and plasma samples from 2,171 individuals drawn from multiple cohorts, including the Global Neurodegeneration Proteomics…
Nature Medicine – The largest harmonized proteomic dataset of plasma, serum and cerebrospinal fluid samples across major neurodegenerative diseases reveals both disease-specific and transdiagnostic…
Nature Medicine – The largest harmonized proteomic dataset of plasma, serum and cerebrospinal fluid samples across major neurodegenerative diseases reveals both disease-specific and transdiagnostic…
Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience,…
Global economic development has been associated with an increased prevalence of obesity and related health problems. Increased caloric intake and r…
